Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats

Objective: Sotagliflozin is a dual sodium-glucose co-transporter-1 and 2 (SGLT1/2) inhibitor with selectivity towards SGLT2. Previous studies showed that SGLT2 inhibitors can improve cardiac function and reduce myocardial infarction size in animal models of myocardial infarction (MI). However, it re...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Peng Zhong, Jingjing Zhang, Yanzhao Wei, Tao Liu, Minxiao Chen
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Subjects:	Sotagliflozin Myocardial infarction Cardiac remodeling Inflammation SGLT1 SGLT2
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023096317